Levine claimed the company is building on past investigation that displays the protection and effectiveness with the drug. "That gives us plenty of hope that possibly inside of a number of years' time we could deliver this through regulatory acceptance and hopefully to patients who really need it.""To view and witness this kind of profundity in tha